Atlas Trials

Neoadjuvant Immunotherapy in Advanced NSCLC

Clinical trial NCT05137912 · UNKNOWN

Trial details

NCT number
NCT05137912
Sponsor
Power Life Sciences Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer, Non-small Cell
Start date
2022-02-01
Primary completion
2022-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.